Release Date: 18/12/17 08:03 Summary: Aconex Board Recommends Acquisition Proposal by Oracle Price Sensitive: Yes Download Document 614.27KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%